Clinical Trial Detail

NCT ID NCT02193152
Title Pazopanib in Molecularly Selected Patients With Advanced NSCLC
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Washington University School of Medicine
Indications

lung non-small cell carcinoma

Therapies

Pazopanib

Age Groups: senior adult

Additional content available in CKB BOOST